Year-over-year earnings per share growth for the last twelve months: Onconetix, Inc. (ONCO)

Corporate emblem and logo of Onconetix, Inc. (ONCO)

Reagent disposal challenges and environmental regulations create certain costs, as evidenced by the quarterly EPS growth history. The current 99.40 metric indicates a status of financial stability. Meanwhile, Onconetix, Inc. (ONCO) management is actively commercializing urological innovations, and the absence of geopolitical conflicts in the Western sector provides the company with a stable and secure operational environment.

Onconetix (ONCO) Earnings per share growth in annualized terms for the last twelve months: for the period 02/21/2024 - 11/17/2026

Analytical breakdowns and data insights for company onconetix.gcs-web.com (ONCO)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Onconetix, Inc.
Flagship merchandise of Onconetix, Inc.

The development of Onconetix, Inc. (ONCO) is based on the launch of diagnostic and therapeutic oncology products, which renders the business autonomous from macroeconomic factors. By analyzing the quarterly EPS growth vector, an investor assesses the dynamics of net income per share, separating real returns from accounting adjustments, where an upward trend signals the capitalization of success, while a decline indicates a risk of fundamental drawdown.

Key competitors

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XGN (exagen.com)|MDxHealth Inc. - Year-over-year earnings per share growth for the last twelve months|Lucid Diagnostics, Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Prenetics Global Limited PRE|Insight Molecular (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB (Trinity Biotech PLC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months ProPhase Labs|Ainos (AIMD) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Biomerica BMRA|CDIO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months